Multidrug Resistant Tuberculosis Recruiting Phase 4 Trials for Protionamide (DB12667)

Also known as: MDR-TB / MDR Tuberculosis / Multidrug-Resistant Tuberculosis / Tuberculosis, Multidrug Resistant / Tuberculosis, MDR / MDR TB / Multi Drug Resistant Tuberculosis / Tuberculosis, Multidrug-Resistant / Multi-Drug Resistant Tuberculosis / TB Multi-drug Resistant / Multidrug resistant tuberculosis (disorder) / Tuberculosis / Tuberculosis (disorder) / Tuberculosis NOS / Tuberculosis NOS (disorder) / Infection TBC / Infection tuberculosis / Infection caused by Mycobacterium tuberculosis (disorder) / TB / Tuberculous (disorder) / Tuberculous (qualifier value) / Tuberculous infections

DBCOND0041129 (Multidrug Resistant Tuberculosis)Recruiting4 IdentifierTitlePurposeDrugs
NCT05306223A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in ChinaTreatment